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Commentary
The article by Balling and associates addresses the
very important issue of intracardiac thrombus forma-
tion and its possible prevention by routine anticoagula-
tion in patients after the Fontan procedure. Thrombo-
embolic stroke in a child is a devastating complication
that often has lifelong consequences for the child and
family. Furthermore, evidence is steadily accumulating
that there is indeed a procoagulant state with Fontan
physiology. For example, recent work by Jahangiri and
associates, both in London and in Boston, has demon-
strated a decreased level of protein C and protein S, as
well as an increase in some procoagulant factors.
Balling and associates reviewed the case histories of
52 patients late after a Fontan procedure. All patients
had undergone transesophageal echocardiographic
(TEE) studies as part of a program intended to identify
the incidence of thrombus in these patients, although it
appears that much of the non-TEE patient-related data
were not collected prospectively, but through a retro-
spective chart review. They identified a remarkably
high incidence of intra-atrial thrombi (almost all in the
right atrium), although not inconsistent with previous
reports. They conclude that routine TEE is probably
justified for patients after the Fontan procedure and that
routine anticoagulation is probably advisable.
Before accepting the recommendations of Balling
and associates, it is important to recognize some sig-
nificant limitations of their report. As noted above, this
is effectively a retrospective review of a selected group
of patients who agreed to the TEE procedure. Most
patients had undergone their Fontan operation many
years before, and therefore only 9 of the 52 had had lat-
eral tunnel–type Fontan procedures. Most had had the
old-style right atrium–pulmonary artery anastomosis.
Only 7 had a fenestration. Interestingly, none of the
patients with a fenestration had detectable thrombus.
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None of the patients had had a recent thromboembolic
event that was symptomatic, and of the 3 patients who
had had cerebrovascular events in the past, none had
identifiable thrombus by TEE.
With respect to the recommendation regarding anti-
coagulation, it is important to note that thrombi devel-
oped in 7 of these patients despite warfarin sodium
(Coumadin) anticoagulation, although the authors
would argue that some of these patients at least did not
have adequate anticoagulation. The risks of anticoagu-
lation need to be balanced against the morbidity of
asymptomatic thrombi detected by routine screening.
The risks of routine screening also need to be carefully
considered when one notes that nearly 50% of this pop-
ulation required general anesthesia to undergo the TEE
procedure.
The technique of TEE is probably quite sensitive to
detect intra-atrial thrombi, but the authors have not
addressed the specificity of the method. They are now
embarking on a study in which magnetic resonance
imaging will be used to exclude false positive results,
but until the results of that investigation and others
are available, it is hard to support the aggressive rec-
ommendation for routine TEE and routine anticoagu-
lation in this difficult patient population. Never-
theless, a provocative report such as this article by
Balling and associates does highlight the importance
once again of urgently completing at least one (and
ideally more than one) carefully organized prospec-
tive randomized study to address the issue of war-
farin sodium versus aspirin versus no anticoagulation
in patients after the Fontan procedure. It is important
that such studies have sensitive and specific methods
for intracardiac thrombus formation, as well as care-
ful prospective assessment for symptoms and signs of
thromboembolic events.
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